Insights On Enterprise Solutions

  1. A Trusted New Partnership 1/28/2026

    Optima delivers high‑quality, flexible syringe and vial filling solutions with fast qualification, U.S.‑based support, and long‑term partnership reliability, helping CDMOs scale efficiently and confidently.

  2. Handling Demanding Active Ingredients Safely And Efficiently 1/27/2026

    See three flexible Optima fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.

  3. Putting Pressure On CDMOs With Herman Bozenhardt 1/27/2026

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Herman Bozenhardt, a consultant and industry veteran who has spent decades advancing the fields of biopharmaceutical manufacturing, engineering, and regulatory compliance.

  4. Selecting A CDMO For Custom Activated PEGs 1/27/2026

    Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.

  5. Commercially Proven Sterile Fill/Finish With Capacity And Global Backing 1/27/2026

    Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

  6. Drug Product Development: Preclinical To Commercial 1/26/2026

    Watch a unified roadmap for drug product development, outlining phase‑appropriate studies, QTTP importance, and key requirements from preclinical stages through commercialization.

  7. Understanding Surfactant Excipients In Biologic Formulations 1/26/2026

    Uncover surfactant characterization, polysorbate degradation, and advanced analytics, such as multidimensional LC, to strengthen stability assessment and formulation for biologics and advanced therapies.

  8. Subvisible Particle Analysis For End‑To‑End Quality 1/26/2026

    See strategies for precise subvisible particle analysis, covering regulatory expectations, method validation, and controlling variability when transitioning workflows from R&D to GMP environments.

  9. Building A Path To A Successful AAV Product 1/26/2026

    See state‑of‑the‑art analytical methods for AAV characterization, key quality attributes to monitor, and approaches for measuring infectivity and full‑to‑empty capsid ratios.

  10. Lyo‑Modelling For Risk Reduction And Process Insights 1/26/2026

    Use lyophilization modelling to optimize freeze‑drying, boost product quality, and lower commercialization risks through predictive insights, robustness analysis, and deeper process understanding.